Peter Spégel
51 – 60 of 96
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion
(
- Contribution to journal › Article
-
Mark
Unique and Shared Metabolic Regulation in Clonal β-cells and Primary Islets Derived from Rat Revealed by Metabolomics Analysis.
(
- Contribution to journal › Article
-
Mark
Short- and Long-Term Hormonal and Metabolic Consequences of Reversing Gastric Bypass to Normal Anatomy in a Type 2 Diabetes Patient.
(
- Contribution to journal › Article
-
Mark
Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Deletion of glycerol channel aquaporin-9 (Aqp9) impairs long-term blood glucose control in C57BL/6 leptin receptor-deficient (db/db) obese mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Loss of TFB1M results in mitochondrial dysfunction that leads to impaired insulin secretion and diabetes.
(
- Contribution to journal › Article
-
Mark
Chronic high glucose and pyruvate levels differentially affect mitochondrial bioenergetics and fuel-stimulated insulin secretion from clonal INS-1 832/13 cells.
(
- Contribution to journal › Article
-
Mark
Glucose-dependent insulinotropic polypeptide lowers branched chain amino acids in hyperglycemic rats.
(
- Contribution to journal › Article
-
Mark
Gastric bypass improves ss-cell function and increases β-cell mass in a porcine model.
(
- Contribution to journal › Article
-
Mark
Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist.
(
- Contribution to journal › Article